Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
about
Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosisCharacterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imagingFrom fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases.Characterization of white matter damage in animal models of multiple sclerosis by magnetization transfer ratio and quantitative mapping of the apparent bound proton fraction f.mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis.Composite MRI scores improve correlation with EDSS in multiple sclerosisIncreased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study.RGC-32 Deficiency Protects against Hepatic Steatosis by Reducing Lipogenesis.Advanced Glycation End Products (AGE) Potently Induce Autophagy through Activation of RAF Protein Kinase and Nuclear Factor κB (NF-κB).New imaging techniques in the diagnosis of multiple sclerosis.Translational research in neurology and neuroscience 2010: multiple sclerosisPlacebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis.Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosis.Chronic T2 Lesions in Multiple Sclerosis are Heterogeneous Regarding Phase MR Imaging.Effects of aging on [Formula: see text], [Formula: see text], and QSM MRI values in the subcortex.A novel approach with "skeletonised MTR" measures tract-specific microstructural changes in early primary-progressive MS.A phosphorylation cascade controls the degradation of active SREBP1.Regionally distinct white matter lesions do not contribute to regional gray matter atrophy in patients with multiple sclerosis.Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis.Tissue-specific MR imaging in multiple sclerosis.Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNβ-1a in multiple sclerosis.Gender-related differences in MS: a study of conventional and nonconventional MRI measures.
P2860
Q21560827-DC90D41C-8A5A-417F-9A9F-D4EE69895591Q24645501-A66872B4-284F-4584-A209-9A21484C8784Q31155244-5C39CBDF-6F58-4B46-BD88-8FF6E5E0BB9BQ33381171-4F7F1413-88A5-46BE-B521-CD6007B330FDQ33734395-9F071F01-B919-4188-8F9E-36DCFA929FF7Q34109873-C1C7D11C-9C18-4096-943E-C740AC958EFDQ34988315-6C97500D-AA94-4D4E-B754-AE7468973076Q35119866-9F355BC8-2C16-40D6-B763-7352FF364C9EQ35953156-AC18F6AE-0764-49CC-97BD-08EBCC262B10Q36466224-B60919E7-799A-4F8D-A06E-CB6E5B9F5328Q37428790-890DAE1B-FF39-45DB-80F4-4D32C098B597Q37772026-A2E7095B-D388-49BA-BA29-336D0E9E79D3Q38444650-BF41C4E3-2D13-4FFF-BD5E-3AEA20E9537BQ39896001-86F18947-EED7-47F7-930C-BB7A6BB3B2A9Q40066578-36B0E8D5-48D3-4BF1-ABF0-A30431B5131DQ41038171-26EF2315-3994-40E2-966A-AB0D0D36F94FQ41223199-75B93F34-1D13-4B86-9087-8D0057E40877Q43677322-5C39F2C6-69CA-4305-BB9E-4B2B80D8B28BQ46173456-E157C4A9-BC9F-459A-875C-224C19590D2CQ48227724-F02F8951-0647-4882-94F8-61505D7CD1BAQ48415746-9EDAC8FE-2546-46F2-8BDF-8701CA232905Q48515820-33077CCF-188A-4174-8C36-2E3486482558Q48756889-89F7ECA6-7B99-4CEC-86DB-2EFFD15D9836Q51672793-CB9D5F31-07BA-4A2A-AED8-7A9EFCFAA544
P2860
Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
@ast
Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
@en
type
label
Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
@ast
Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
@en
prefLabel
Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
@ast
Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
@en
P1433
P1476
Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
@en
P304
S72-82; discussion S91-6
P356
10.1212/01.WNL.0000275236.51129.D2
P407
P433
22 Suppl 3
P577
2007-05-01T00:00:00Z